The forecast for Germany's production of antisera, other immunological products, and other blood fractions indicates a steady upward trend. From 2024 to 2028, the market is anticipated to grow from 1.784 to 1.8853 billion Euros. In comparison to 2023, these figures suggest a consistent yearly increase in production value. The year-on-year percentage growth from 2024 to 2028 averages around 1.42%. The compound annual growth rate (CAGR) over the 5-year period is approximately 1.41%.
Future trends to watch for include:
- Increased demand driven by advancements in medical research and biotechnology.
- Regulatory changes and their potential impact on production efficiency.
- Technological innovations in immunological product development.
